These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2964112)

  • 21. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D; Chen JH; Wu WZ; Yang SL; Wu GJ; Wang H; Tan JM
    Transplant Proc; 2007; 39(1):69-72. PubMed ID: 17275476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of three immunosuppressive regimens in high-risk patients: immunologic aspects.
    Renna Molajoni E; Bachetoni A; Cinti P; Sallustio F; Rossi M; Pretagostini R; Orlandini A; Berloco P; Alfani D; Cortesini R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1978-80. PubMed ID: 3079064
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model.
    Reichenspurner H; Human PA; Rose AG; Reichart B; Cooper DK
    Transplant Proc; 1990 Jun; 22(3):1086-7. PubMed ID: 2349666
    [No Abstract]   [Full Text] [Related]  

  • 24. Utility of an in vitro immunoassay to guide immunosuppressive therapy.
    Pollak R; Dumble LJ; Lazda VA; Maddux MS; Stormoen B; Ward M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1113-4. PubMed ID: 1824889
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithymocyte globulin as the primary treatment for renal allograft rejection.
    Nelson PW; Cosimi AB; Delmonico FL; Rubin RH; Tolkoff-Rubin NE; Fang L; Russell PS
    Transplantation; 1983 Nov; 36(5):587-9. PubMed ID: 6356523
    [No Abstract]   [Full Text] [Related]  

  • 26. [After care of kidney transplant patients].
    Castro LA; Eigler J; Land W
    Internist (Berl); 1983 Sep; 24(9):510-6. PubMed ID: 6313541
    [No Abstract]   [Full Text] [Related]  

  • 27. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD; Flemming C
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of steroid-resistant lymphoid populations in renal dialysis patients: association with pretransplant transfusion.
    Bowes LG; Dumble LJ; Clunie GJ; Macdonald IM; Kincaid-Smith P
    Transplant Proc; 1986 Apr; 18(2):281-4. PubMed ID: 2938315
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum erythropoietin and parathyroid hormone concentrations in kidney transplant patients during acute graft rejection.
    Kokot F; Wiecek A; Grzeszczak W; Lao M; Kuśmierski S; Cierpka L; Gradowska L; Jagiełło R
    Transplant Proc; 1996 Dec; 28(6):3477-9. PubMed ID: 8962352
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 31. Individualized immunosuppression in heart transplant recipients.
    Haverich A; Frimpong-Boateng K; Schäfers HJ; Wahlers T; Fieguth HG; Herrmann G; Wonigeit K; Borst HG
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2514-5. PubMed ID: 3274552
    [No Abstract]   [Full Text] [Related]  

  • 32. Control of rejection of transplanted organs.
    Keown PA; Stiller CR
    Adv Intern Med; 1986; 31():17-46. PubMed ID: 3511616
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of cardiac transplant rejection without massive immunosuppression.
    Michler RE; Smith CR; Drusin RE; Reison DS; Hickey TJ; Lamb J; Reemtsma K; Rose EA
    Circulation; 1986 Nov; 74(5 Pt 2):III68-71. PubMed ID: 3533317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients.
    Wieneke H; Otte B; Lang D; Heidenreich S
    Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression in renal transplantation.
    Hall BM
    Med J Aust; 1982 Oct; 2(9):415-8. PubMed ID: 6757689
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 39. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
    Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
    Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of kidney transplantation in highly sensitized patients after donor-specific blood transfusion.
    Takahashi K; Yagisawa T; Tanabe I; Teraoka S; Hayasaka Y; Yasuo M; Fuchinoue S; Honda H; Toma H; Agishi T
    Transplant Proc; 1987 Oct; 19(5):3655-60. PubMed ID: 2960043
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.